Evaluation of the toxicity at Day 100 (NCI/NIH Common Toxicity Criteria) of Extracorporal Photopheresis (ECP) administered for Graft-versus-host-disease (GVHD) prophylaxis and introduced early (Day 21) after an HSCT from a genoidentical donor. Day 100 [clinicaltrials_resource:103047a33318fd36d99a91ecad07924e]
All types of toxicity will be assessed and graded according to NCI/NIH Common Toxicity Criteria
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Evaluation of the toxicity at Day 100 (NCI/NIH Common Toxicity Criteria) of Extracorporal Photopheresis (ECP) administered for Graft-versus-host-disease (GVHD) prophylaxis and introduced early (Day 21) after an HSCT from a genoidentical donor. Day 100 [clinicaltrials_resource:103047a33318fd36d99a91ecad07924e]
All types of toxicity will be assessed and graded according to NCI/NIH Common Toxicity Criteria
Bio2RDF identifier
103047a33318fd36d99a91ecad07924e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:103047a33318fd36d99a91ecad07924e
measure [clinicaltrials_vocabulary:measure]
Evaluation of the toxicity at ...... CT from a genoidentical donor.
time frame [clinicaltrials_vocabulary:time-frame]
description
All types of toxicity will be ...... I/NIH Common Toxicity Criteria
identifier
clinicaltrials_resource:103047a33318fd36d99a91ecad07924e
title
Evaluation of the toxicity at ...... a genoidentical donor. Day 100
@en
type
label
Evaluation of the toxicity at ...... 047a33318fd36d99a91ecad07924e]
@en